- Home
- TCRX vs TCBS Comparison
TCRX vs TCBS Comparison
Compare TCRX & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TCRX | TCBS |
|---|---|---|
| Founded | 2018 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.4M | 50.6M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TCRX | TCBS |
|---|---|---|
| Price | $0.31 | $17.15 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 1.5K |
| Earning Date | 05-08-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | 12.28 | ★ 327.27 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $10,325,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $19.81 | N/A |
| P/E Ratio | ★ N/A | $25.76 |
| Revenue Growth | ★ 266.65 | N/A |
| 52 Week Low | $0.29 | $15.72 |
| 52 Week High | $2.57 | $20.00 |
Technical Indicators
Market Signals| Indicator | TCRX | TCBS |
|---|---|---|
| Relative Strength Index (RSI) | 21.36 | 50.89 |
| Support Level | N/A | $17.23 |
| Resistance Level | $0.82 | $17.92 |
| Average True Range (ATR) | 0.05 | 0.11 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 4.94 | 44.44 |
Price Performance
Historical ComparisonAbout TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans, commercial real estate loans, and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer, and other.